Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials
Loupakis Fotios, Bria Emilio, Vaccaro Vanja, Cuppone Federica, Milella Michele, Carlini Paolo, Cremolini Chiara, Salvatore Lisa, Falcone Alfredo, Muti Paola, Sperduti Isabella, Giannarelli Diana, Cognetti Francesco